Matches in SemOpenAlex for { <https://semopenalex.org/work/W2937273501> ?p ?o ?g. }
- W2937273501 endingPage "265" @default.
- W2937273501 startingPage "258" @default.
- W2937273501 abstract "Prostate-specific membrane antigen (PSMA) is a transmembrane protein that is highly expressed on the surface of prostate cancer (PC) cells, making it an excellent radiotracer for both therapeutic and diagnostic purposes. In this prospective study, we investigated the efficacy and toxicity of 177Lutetium (Lu)-PSMA in metastatic castration-resistant PC (mCRPC) patients for the establishment and approval of this therapy in Iran. Fourteen mCRPC patients (mean age 70.57 ± 7.3 years) were treated with a single dose of 177Lu-PSMA. Complete blood count, liver function tests (aspartate aminotransferase and alanine aminotransferase), alkaline phosphatase levels, renal function tests (urea and creatinine), and prostate-specific antigen (PSA) levels were obtained for the patients at baseline and every 2 weeks. A majority of the patients (11 patients, 64.2%) experienced a decline in their PSA levels; in 5 (45.4%) of these patients, the PSA levels declined > 50%.The severity of pain decreased in 8 (57.1%) patients, and performance status was improved in 5 (45.4%) patients. The treatment was well tolerated, and no severe hematological or nonhematological side effects were observed. Our findings show that 177Lu-PSMA had a high efficacy and a low toxicity in an Iranian population and is a promising treatment option for PC patients." @default.
- W2937273501 created "2019-04-25" @default.
- W2937273501 creator A5001442023 @default.
- W2937273501 creator A5033500654 @default.
- W2937273501 creator A5054033603 @default.
- W2937273501 creator A5061905483 @default.
- W2937273501 creator A5063166479 @default.
- W2937273501 creator A5064189017 @default.
- W2937273501 creator A5067763296 @default.
- W2937273501 creator A5084945071 @default.
- W2937273501 creator A5087071587 @default.
- W2937273501 date "2019-07-01" @default.
- W2937273501 modified "2023-09-24" @default.
- W2937273501 title "Efficacy and safety of 177Lutetium-prostate-specific membrane antigen therapy in metastatic castration-resistant prostate cancer patients: First experience in West Asia – A prospective study" @default.
- W2937273501 cites W104465619 @default.
- W2937273501 cites W1497206380 @default.
- W2937273501 cites W1546799663 @default.
- W2937273501 cites W1979538859 @default.
- W2937273501 cites W200091782 @default.
- W2937273501 cites W2027847537 @default.
- W2937273501 cites W2040935952 @default.
- W2937273501 cites W2055346449 @default.
- W2937273501 cites W2080439368 @default.
- W2937273501 cites W2118721274 @default.
- W2937273501 cites W2123526148 @default.
- W2937273501 cites W2147136637 @default.
- W2937273501 cites W2148643283 @default.
- W2937273501 cites W2158734599 @default.
- W2937273501 cites W2160881737 @default.
- W2937273501 cites W2163470211 @default.
- W2937273501 cites W2290847925 @default.
- W2937273501 cites W2302508993 @default.
- W2937273501 cites W2315998085 @default.
- W2937273501 cites W2511755939 @default.
- W2937273501 cites W2525124727 @default.
- W2937273501 cites W2532226140 @default.
- W2937273501 cites W2589729932 @default.
- W2937273501 cites W2599305587 @default.
- W2937273501 cites W2612027160 @default.
- W2937273501 cites W2762824224 @default.
- W2937273501 cites W2763185726 @default.
- W2937273501 cites W2768439034 @default.
- W2937273501 cites W2768513671 @default.
- W2937273501 cites W2781525129 @default.
- W2937273501 cites W2799931007 @default.
- W2937273501 cites W2807406579 @default.
- W2937273501 doi "https://doi.org/10.4103/wjnm.wjnm_66_18" @default.
- W2937273501 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/6714159" @default.
- W2937273501 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/31516369" @default.
- W2937273501 hasPublicationYear "2019" @default.
- W2937273501 type Work @default.
- W2937273501 sameAs 2937273501 @default.
- W2937273501 citedByCount "21" @default.
- W2937273501 countsByYear W29372735012019 @default.
- W2937273501 countsByYear W29372735012020 @default.
- W2937273501 countsByYear W29372735012021 @default.
- W2937273501 countsByYear W29372735012022 @default.
- W2937273501 countsByYear W29372735012023 @default.
- W2937273501 crossrefType "journal-article" @default.
- W2937273501 hasAuthorship W2937273501A5001442023 @default.
- W2937273501 hasAuthorship W2937273501A5033500654 @default.
- W2937273501 hasAuthorship W2937273501A5054033603 @default.
- W2937273501 hasAuthorship W2937273501A5061905483 @default.
- W2937273501 hasAuthorship W2937273501A5063166479 @default.
- W2937273501 hasAuthorship W2937273501A5064189017 @default.
- W2937273501 hasAuthorship W2937273501A5067763296 @default.
- W2937273501 hasAuthorship W2937273501A5084945071 @default.
- W2937273501 hasAuthorship W2937273501A5087071587 @default.
- W2937273501 hasBestOaLocation W29372735011 @default.
- W2937273501 hasConcept C121608353 @default.
- W2937273501 hasConcept C126322002 @default.
- W2937273501 hasConcept C126894567 @default.
- W2937273501 hasConcept C143998085 @default.
- W2937273501 hasConcept C159641895 @default.
- W2937273501 hasConcept C160160445 @default.
- W2937273501 hasConcept C181199279 @default.
- W2937273501 hasConcept C185592680 @default.
- W2937273501 hasConcept C188816634 @default.
- W2937273501 hasConcept C20417620 @default.
- W2937273501 hasConcept C2776235491 @default.
- W2937273501 hasConcept C2780192828 @default.
- W2937273501 hasConcept C2780306776 @default.
- W2937273501 hasConcept C2781406297 @default.
- W2937273501 hasConcept C2908647359 @default.
- W2937273501 hasConcept C29730261 @default.
- W2937273501 hasConcept C55493867 @default.
- W2937273501 hasConcept C71924100 @default.
- W2937273501 hasConcept C90924648 @default.
- W2937273501 hasConcept C99454951 @default.
- W2937273501 hasConceptScore W2937273501C121608353 @default.
- W2937273501 hasConceptScore W2937273501C126322002 @default.
- W2937273501 hasConceptScore W2937273501C126894567 @default.
- W2937273501 hasConceptScore W2937273501C143998085 @default.
- W2937273501 hasConceptScore W2937273501C159641895 @default.
- W2937273501 hasConceptScore W2937273501C160160445 @default.
- W2937273501 hasConceptScore W2937273501C181199279 @default.
- W2937273501 hasConceptScore W2937273501C185592680 @default.
- W2937273501 hasConceptScore W2937273501C188816634 @default.